How much funding has Primaa raised?

Primaa has raised $7.8M in total funding, most recently a Series B round.

Who are Primaa's investors?

Primaa's investors include Elaia, Swen CP, Super Ventures.

Where is Primaa headquartered?

Primaa is headquartered in Paris, France.

What industry is Primaa in?

Primaa operates in Artificial Intelligence, Biotech, Healthcare.

Primaa

Paris, France · Founded 2018 · $7.8M raised

Artificial Intelligence

Biotech

Healthcare

Headquarters: Paris
Employees: 11–50
Founded: 2018
Business Model: B2B

Website: primaalab.com
Total Funding: $7.8M
Last Round: $7.8M Series BOct 2025
Rounds: 3

About

Primaa is a MedTech company developing AI-based software for automated cancer diagnosis in histopathology. Founded in 2018 in Paris by pathologist Marie Sockeel, the company flagship product Cleo uses deep learning and computer vision to assist pathologists in identifying cancer biomarkers on whole slide images, with CE-marked solutions for breast cancer and — as of 2026 — the world first CE IVDR-certified AI tool for dermatopathology. With a team of 22 including PhDs, MDs, and data scientists, Primaa partners with leading digital pathology platforms including PathAI, Proscia, and Gestalt, and has expanded into the U.S. market.

Summary

Primaa is an Artificial Intelligence company based in Paris, France, founded in 2018. It has raised $7.8M in total across 3 rounds, most recently a $7.8M Series B round in Oct 2025. Investors include Elaia, Swen CP and Super Ventures.